Geisinger Medical Oncology-Selinsgrove — Selinsgrove, Pennsylvania

Geisinger Medical Oncology-Selinsgrove is a clinical research site located in Selinsgrove, Pennsylvania, United States 17870.

Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.

Geisinger Medical Oncology-Selinsgrove has participated in 87 clinical trials with 55 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, NRG Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Selinsgrove

Browse all research sites in Pennsylvania · View every site in Selinsgrove

Sponsor Feasibility Report

Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Geisinger Medical Oncology-Selinsgrove?

Geisinger Medical Oncology-Selinsgrove has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Geisinger Medical Oncology-Selinsgrove conducted?

Geisinger Medical Oncology-Selinsgrove has 87 clinical trials on record, with 55 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Geisinger Medical Oncology-Selinsgrove accredited by Crixeo Clinical Trials?

Geisinger Medical Oncology-Selinsgrove has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Geisinger Medical Oncology-Selinsgrove?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.